project_name,project_description,primary_disease,study_name,longitudinal,study_description
Parkinson's Progression Markers Initiative,"The Parkinson's Progression Markers Initiative (PPMI) is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest using advanced imaging, biologic sampling and clinical and behavioral assessments to identify biomarkers of Parkinson's disease progression.",Parkinson's,Parkinson's Disease,1,Subjects with a diagnosis of PD for two years or less who are not taking PD medications.
Parkinson's Progression Markers Initiative,"The Parkinson's Progression Markers Initiative (PPMI) is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest using advanced imaging, biologic sampling and clinical and behavioral assessments to identify biomarkers of Parkinson's disease progression.",Parkinson's,Healthy Control,1,Control Subjects without PD who are 30 years or older and who do not have a first degree blood relative with PD.
Parkinson's Progression Markers Initiative,"The Parkinson's Progression Markers Initiative (PPMI) is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest using advanced imaging, biologic sampling and clinical and behavioral assessments to identify biomarkers of Parkinson's disease progression.",Parkinson's,SWEDD,1,Subjects consented as PD subjects who have DaTscans that do not show evidence of a dopaminergic deficit.
Parkinson's Progression Markers Initiative,"The Parkinson's Progression Markers Initiative (PPMI) is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest using advanced imaging, biologic sampling and clinical and behavioral assessments to identify biomarkers of Parkinson's disease progression.",Parkinson's,Prodromal,1,Subjects without Parkinson's disease who have a diagnosis of hyposmia or REM sleep behavior disorder (RBD).
Parkinson's Progression Markers Initiative,"The Parkinson's Progression Markers Initiative (PPMI) is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest using advanced imaging, biologic sampling and clinical and behavioral assessments to identify biomarkers of Parkinson's disease progression.",Parkinson's,Genetic Cohort,1,"Subjects with and without Parkinson's disease who have a genetic mutation in LRRK2, GBA, or SNCA."
Parkinson's Progression Markers Initiative,"The Parkinson's Progression Markers Initiative (PPMI) is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest using advanced imaging, biologic sampling and clinical and behavioral assessments to identify biomarkers of Parkinson's disease progression.",Parkinson's,Genetic Registry,1,"Subjects with and without Parkinson's disease who have a genetic mutation in LRRK2, GBA, or SNCA or a first-degree relative with a LRRK2, GBA, or SNCA mutation who are evaluated at less frequent intervals to augment and broaden the follow-up of PD subjects and family members with PD associated mutations ."
Parkinson's Progression Markers Initiative,"The Parkinson's Progression Markers Initiative (PPMI) is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest using advanced imaging, biologic sampling and clinical and behavioral assessments to identify biomarkers of Parkinson's disease progression.",Parkinson's,Unknown,1,Subjects for whom no study was assigned.